There are 749 resources available
Recent advances in metastatic prostate cancer management
Presenter: Shahneen Sandhu
Session: AstraZeneca - PARP inhibitors as targeted therapy for personalised medicine
Resources:
Slides
Webcast
Expert Opinion on ‘PARP inhibitors as targeted therapy for personalized medicine’ - Panel Discussion
Presenter: John Chia
Session: AstraZeneca - PARP inhibitors as targeted therapy for personalised medicine
Resources:
Slides
Webcast
Closing
Presenter: Byoung-Gie Kim
Session: AstraZeneca - PARP inhibitors as targeted therapy for personalised medicine
Resources:
Slides
Immune-Check Points Inhibitors (ICI) in non-oncogenic addicted mNSCLC
Presenter: Marina Garassino
Session: ESMO Colloquium supported by Lilly Oncology: Biomarker-driven treatment decision in metastatic NSCLC
Resources:
Slides
Webcast
EGFR mutant mNSCLC: Single agent or in combination?
Presenter: Fabrice Barlesi
Session: ESMO Colloquium supported by Lilly Oncology: Biomarker-driven treatment decision in metastatic NSCLC
Resources:
Slides
Webcast
Future development for the use of biomarkers
Presenter: Ross Soo
Session: ESMO Colloquium supported by Lilly Oncology: Biomarker-driven treatment decision in metastatic NSCLC
Resources:
Slides
Webcast
HR-positive advanced breast cancer: CDK4 inhibitors, who and when
Presenter: Shom Goel
Session: Integrating new treatment paradigms in breast cancer care in 2019
Resources:
Slides
Webcast
Clinical applications of circulating tumour DNA in advanced setting
Presenter: Fortunato Ciardiello
Session: Precision medicine in advanced gastrointestinal cancer
Resources:
Slides
Webcast
Targeted treatment in gastroesophageal cancer: The present and the future
Presenter: Sylvie Lorenzen
Session: Precision medicine in advanced gastrointestinal cancer
Resources:
Slides
Webcast
Surgical management: When and how?
Presenter: Keiichi Fujiwara
Session: Contemporary issues in cervical cancer management
Resources:
Slides
Webcast